Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to evaluate the performance and safety of the Caterpillar™ Arterial Embolization Device when used for arterial embolization in the peripheral vasculature in a real world, on-label application.


Clinical Trial Description

The post-market study is a prospective, multi-center, single-arm, real world study of the Caterpillar™ Arterial Embolization Device. Enrollment will continue until up to fifty (50) subjects have been treated with the Caterpillar™ Arterial Embolization Device at up to 20 investigational sites in the United States. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04244370
Study type Interventional
Source C. R. Bard
Contact
Status Completed
Phase N/A
Start date April 30, 2020
Completion date August 12, 2022

See also
  Status Clinical Trial Phase
Completed NCT04090320 - CATERPILLAR™ Arterial Embolization Device Study N/A
Recruiting NCT05531240 - Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE) N/A
Recruiting NCT03853434 - Efficacy of Angiographic Embolization vs Non-embolization of Moderate/Poor Vascularized Vertebral Metastases on Intraoperative Bleeding During Surgery Decompression and Vertebral Stabilization. N/A
Recruiting NCT04115137 - Pelvic Varicose Veins Treated With Vascular Plugs Type Amplatzer: REPiVAC
Not yet recruiting NCT03805087 - Transarterial Coil Embolization of the Superior Rectal Arteries for Treatment of Stage II Hemorrhoids N/A